JTJordan Tanley

Jordan Tanley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jordan Tanley has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Haiying Chen

    Department of Biostatistics and Data Science Division of Public Health Sciences Wake Forest University School of Medicine Winston‐Salem North Carolina USA

    3 shared publications
  • Jingzhong Ding

    Department of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest University School of Medicine Winston‐Salem North Carolina USA

    3 shared publications
  • Kathleen M. Hayden

    Department of Social Sciences and Health Policy Division of Public Health Sciences Wake Forest University School of Medicine Winston‐Salem North Carolina USA

    3 shared publications
  • Yongmei Liu

    Department of Medicine Division of Cardiology Duke Molecular Physiology Institute Duke University School of Medicine Durham North Carolina USA

    3 shared publications
  • Alain G. Bertoni

    Division of Public Health Sciences Wake Forest University School of Medicine Winston‐Salem North Carolina USA

    2 shared publications
  • Bonnie C. Sachs

    Department of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest University School of Medicine Winston‐Salem North Carolina USA

    2 shared publications

Latest Publications

  • Open Access

    The reduction in blood pressure required to reduce arterial stiffness components in SPRINT: a randomized controlled trial

    by Theodore M. DeConne, Jordan Tanley, Ryan Pewowaruk, Deepika Laddu, Cecilia Peterson, Adam D. Gepner, Timothy M. Hughes, Mark A. Supiano

    We examined the extent to which blood pressure (BP) control in the Systolic Blood Pressure Intervention Trial affects arterial stiffness and its associated components. We observed that reductions in blood pressure caused by antihypertensive medication lower total arterial stiffness through a load-dependent (blood pressure-dependent) mechanism, but are insufficient to lower arterial stiffness caused by structural remodeling over 1 yr. Therapeutic approaches independent of BP control are needed to reduce structural arterial stiffness.

  • Open Access

    Subclinical vascular burden in relation to cognitive decline and impairment: The Multi‐Ethnic Study of Atherosclerosis (MESA)

    by Jordan Tanley, Byron C. Jaeger, Haiying Chen, Marc D. Rudolph, Kathleen M. Hayden, José A. Luchsinger, Jingzhong Ding, Yongmei Liu, Alain G. Bertoni, Susan R. Heckbert, et al.

    INTRODUCTION: Subclinical cardiovascular disorders may be differentially associated with cognitive function, decline, and impairment and point to pathways linking vascular disorders to dementia. METHODS: The Multi‐Ethnic Study of Atherosclerosis (MESA) collected detailed subclinical vascular measures at baseline in 6814 participants with follow‐up clinical examinations over 20 years. Baseline subclinical vascular measures aggregated into four uncorrelated factor composites: atherosclerosis, arteriosclerosis, blood pressure, and cardiac function. Cognitive performance was measured 10 years after baseline, repeated twice over the subsequent decade, along with detailed cognitive testing and adjudication. RESULTS: Higher baseline arteriosclerosis and atherosclerosis scores predicted greater cognitive decline, lower performance across multiple domains, and higher odds of mild cognitive impairment and dementia 20 years later. Associations were weaker for cardiac function and blood pressure composites. Stratified analyses confirmed generalizability across subgroups. DISCUSSION: Arteriosclerosis and atherosclerosis were more consistently associated with cognitive impairment and decline than cardiac function and blood pressure in a diverse population over 20 years. Highlights: Subclinical factor relationships varied by cognitive domain and race/ethnicity. These observed associations were independent of clinical risk for dementia. Arteriosclerosis most consistently associated with cognitive function and decline.


  • Open Access

    Subclinical vascular risk composites and dementia imaging biomarkers 17–20 years later in the Multi-Ethnic Study of Atherosclerosis (MESA)

    by Marc D. Rudolph, Jordan Tanley, Jingzhong Ding, Kiran K. Solingapuram Sai, Haiying Chen, Kathleen M. Hayden, Yongmei Liu, R. Nick Bryan, Ilya M. Nasrallah, Sudipto Dolui, et al.


  • Open Access

    Subclinical Vascular Disorders in Relation to Cognitive Decline and Impairment: The Multi‐Ethnic Study of Atherosclerosis

    by Jordan E. Tanley, Byron C Jaeger, Haiying Chen, Marc D. Rudolph, Bonnie C. Sachs, Clara Li, Katya Rascovsky, Jose A. Luchsinger, Kathleen M. Hayden, Jingzhong Ding, et al.

    Background: Vascular disorders are proposed as modifiable risk factors for dementia; yet, physiologic mechanisms connecting vascular disorders to cognitive impairment remain unknown. We examined subclinical cardiovascular measures to determine which predict global cognitive decline and domain specific cognitive impairment and point to potential pathways linking subclinical vascular disease and dementia.Methods: MESA includes a diverse cohort of 6,814 participants free from clinical cardiovascular disease with follow‐up over 6 clinical examinations and annual follow‐up calls. At baseline in 2000‐2002, 24 subclinical vascular measures were collected (e.g., blood pressure, carotid distensibility, artery elasticity index, heart rate, coronary calcification, carotid intima media thickness) that prior work generalized into four uncorrelated factor composites representing: atherosclerosis, arteriosclerosis, blood pressure, and cardiac function (Table 1). During Exam 5, participants began cognitive testing with the Cognitive Abilities Screening Instrument (CASI), which was repeated 10 years later (2010‐2012 to 2019‐2021) and modeled using linear mixed effects models. At Exam 6 (2019‐2021), the Uniform Data Set v3 battery was administered. Scores were normed, grouped into domains (e.g., Memory, Processing Speed, Executive Function) and modeled using generalized linear models. Cognitive impairment was adjudicated as mild cognitive impairment (MCI) or probable dementia and modeled using logistic regression. Results are reported as beta estimates or odds ratios and 95% confidence intervals (95%CI) including adjustment for baseline CAIDE dementia risk score (Figure 1), race/ethnicity, and language.Results: Baseline arteriosclerosis and atherosclerosis were independently associated with greater cognitive decline 10 years later (Figure 1a), lower domain specific cognitive performance (Figure 1b) and higher odds of cognitive impairment 20 years later (Table 2) after multi‐variable adjustment. One standard deviation increase in baseline arteriosclerosis was associated with modestly increased odds of MCI and almost two fold increased odds of probable dementia. Baseline cardiac function and blood pressure were not significantly associated with cognitive decline or impairment beyond CAIDE. Cognitive decline results were generally consistent across racial and ethnic groups (Figure 1c, p‐interaction>0.10).Conclusions: These findings suggest that arteriosclerosis and atherosclerosis are more consistently associated with cognitive impairment and global cognitive decline than cardiac function and blood pressure in a diverse population with 20 years of follow‐up.